ACLY Antibody (N-term) Blocking Peptide

ACLY Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP6784a
Catalog Number: AC-BP6784a
Size: 500 µg
Datasheet
Request Information
Background:
ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine.

Other Names:
ATP-citrate synthase, ATP-citrate (pro-S-)-lyase, ACL, Citrate cleavage enzyme, ACLY

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6784a was selected from the N-term region of human ACLY. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: ACLY

Gene ID: 47
Primary Accession: P53396
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:ACLY Antibody (N-term) Blocking Peptide